Inaugural Solid Tumor Case Review Conference: Challenges with Evolving Therapies in GU Cancer, Lung Cancer and Melanoma

Inaugural Solid Tumor Case Review Conference: Challenges with Evolving Therapies in GU Cancer, Lung Cancer and Melanoma is organized by University of Louisville School of Medicine and would be held on Sep 09, 2017 at Renaissance Chicago Downtown Hotel, Chicago, Illinois, United States Of America.

The target audience for this medical event for Oncologists. This CME Conference has been approved with a maximum of 6.25 AMA PRA Category 1 Credits.

Conference Objectives are :
• Describe where and how checkpoint inhibitors exert their effects on the immune system, allowing them to attack tumor cells and provide robust and often longterm responses in patients being treate for advanced cancers.
• Select the appropriate agent for patients with NSCLC, melanoma, bladder, prostate, or renal cell carcinoma, depending on setting and previous treatment.
• Describe current recommendations about molecular testing and other biomarker studies in patients with advanced/metastatic solid tumors.
• Apply immune-related response criteria to characterize response to checkpoint inhibitor therapy in different tumor types.
• Recognize and know how to mitigate adverse effects related to specific classes of anticancer agents used in patients with advanced solid tumors.
Additional details will be posted as soon as they are available.